Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer

Published:2016-02-22 Issue:14 Volume:7 Page:18424-18439
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Arienti Chiara¹,Zanoni Michele¹,Pignatta Sara¹,Del Rio Alberto²³,Carloni Silvia¹,Tebaldi Michela¹,Tedaldi Gianluca¹,Tesei Anna¹

Affiliation:

1. Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

2. Institute of Organic Synthesis and Photoreactivity (ISOF), National Research Council (CNR), Bologna, Italy

3. Innovamol Srls, Modena, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer;CHINESE J CANCER RES;2024

2. AXL – a new player in resistance to HER2 blockade;Cancer Treatment Reviews;2023-12

3. Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy;Oncogenesis;2023-04-18

4. The IQGAP scaffolds: Critical nodes bridging receptor activation to cellular signaling;Journal of Cell Biology;2023-04-18

5. Plasticity of Cancer Stem Cell;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP